Aerocrine Resolves Apieron Patent Claims In Asset Buy

Law360, New York (May 19, 2010, 1:38 PM EDT) -- Swedish medical technology company Aerocrine AB has bought the business and intellectual property assets of bankrupt rival Apieron Inc., bringing partial resolution to a long-running patent dispute between the companies over lung inflammation monitors.

Aerocrine won the assets in a Chapter 7 bankruptcy auction in the U.S. Bankruptcy Court for the Northern District of California on May 12, the companies announced Wednesday.

As a result, Apieron will dismiss patent infringement claims it asserted against Aerocrine in the U.S. District Court for the District of Delaware, the...
To view the full article, register now.